Heart‐on‐a‐Miniscope: A Miniaturized Solution for Electrophysiological Drug Screening in Cardiac Organoids
Small · 2025
DOI: 10.1002/smll.202409571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Pouria Tirgar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, McGill University, Montreal, H3A 2B4, Canada. Hauptthemen laut MEDLINE: Organoids, Miniaturization, Electrophysiological Phenomena, Heart. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CRBS, NSERC, Government of Canada's New Frontiers in Research Fund.
Abstract (Originalsprache)
Cardiovascular toxicity remains a primary concern in drug development, accounting for a significant portion of post‐market drug withdrawals due to adverse reactions such as arrhythmias. Traditional preclinical models, predominantly based on animal cells, often fail to replicate human cardiac physiology accurately, complicating the prediction of drug‐induced effects. Although human‐induced pluripotent stem cell‐derived cardiomyocytes (hiPSC‐CMs) provide a more genetically relevant system, their use in 2D, static cultures does not sufficiently mimic the dynamic, 3D environment of the human heart. 3D cardiac organoids made from human iPSC‐CMs can potentially bridge this gap. However, most traditional electrophysiology assays, developed for single cells or 2D monolayers, are not readily adaptable to 3D organoids. This study uses optical calcium analysis of human organoids combined with miniaturized fluorescence microscopy (miniscope) and heart‐on‐a‐chip technology. This simple, inexpensive, and efficient platform provides robust on‐chip calcium imaging of human cardiac organoids. The versatility of the system is demonstrated through cardiotoxicity assay of drugs known to impact cardiac electrophysiology, including dofetilide, quinidine, and thapsigargin. The platform promises to advance drug testing by providing a more reliable and physiologically relevant assessment of cardiovascular toxicity, potentially reducing drug‐related adverse effects in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, McGill University, Montreal, H3A 2B4, Canada.
- Center for Structural Biology, McGill University, Montreal, H3G 0B1, Canada.
- Department of Physiology, McGill University, Montreal, H3G 1Y6, Canada.
- Department of Mechanical Engineering, McGill University, Montreal, H3A 0C3, Canada.
- Physical Intelligence Department, Max Planck Institute for Intelligent Systems, 70569, Stuttgart, Germany.
- Department of Cardiovascular Medicine, Osaka University, Osaka, 565-0871, Japan.
ORCID-Profile: Pouria Tirgar, Allen Ehrlicher
Förderung
- CRBS
- NSERC
- Government of Canada's New Frontiers in Research Fund
- Fonds de recherche du Québec - Nature et technologies
- Fonds de Recherche du Québec - Santé
- CIHR
- Natural Sciences and Engineering Research Council of Canada
- Fonds de recherche du Québec – Nature et technologies
Zitieren
APA
Tirgar, P., Vikstrom, A., Sepúlveda, J. M. R., Srivastava, L. K., Amini, A., Tabata, T., Higo, S., Bub, G., & Ehrlicher, A. (2025). Heart‐on‐a‐Miniscope: A Miniaturized Solution for Electrophysiological Drug Screening in Cardiac Organoids. Small. https://doi.org/10.1002/smll.202409571
Vancouver
Tirgar P, Vikstrom A, Sepúlveda JMR, Srivastava LK, Amini A, Tabata T, et al. Heart‐on‐a‐Miniscope: A Miniaturized Solution for Electrophysiological Drug Screening in Cardiac Organoids. Small. 2025. doi:10.1002/smll.202409571
BibTeX
@article{Tirgar2025,
author = {Tirgar, Pouria and Vikstrom, Abigail and Sepúlveda, José Miguel Romero and Srivastava, Luv Kishore and Amini, Ali and Tabata, Tomoka and Higo, Shuichiro and Bub, Gil and Ehrlicher, Allen},
title = {Heart‐on‐a‐Miniscope: A Miniaturized Solution for Electrophysiological Drug Screening in Cardiac Organoids},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202409571}
}
EUVIMED